Acadia Healthcare Company Inc (ACHC) : Next Century Growth Investors scooped up 5,430 additional shares in Acadia Healthcare Company Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 923,622 shares of Acadia Healthcare Company Inc which is valued at $51.8 Million.Acadia Healthcare Company Inc makes up approximately 2.52% of Next Century Growth Investors’s portfolio.
Other Hedge Funds, Including , Laurion Capital Management Lp sold out all of its stake in ACHC during the most recent quarter. The investment firm sold 4,900 shares of ACHC which is valued $274,988.Paradigm Asset Management Co reduced its stake in ACHC by selling 4,100 shares or 66.67% in the most recent quarter. The Hedge Fund company now holds 2,050 shares of ACHC which is valued at $115,046. Acadia Healthcare Company Inc makes up approx 0.02% of Paradigm Asset Management Co’s portfolio. First City Capital Management added ACHC to its portfolio by purchasing 91 company shares during the most recent quarter which is valued at $5,107. Alpine Woods Capital Investors added ACHC to its portfolio by purchasing 7,650 company shares during the most recent quarter which is valued at $429,318. Acadia Healthcare Company Inc makes up approx 0.03% of Alpine Woods Capital Investors’s portfolio.Pembroke Management Ltd reduced its stake in ACHC by selling 125,300 shares or 29.05% in the most recent quarter. The Hedge Fund company now holds 306,045 shares of ACHC which is valued at $17.9 Million. Acadia Healthcare Company Inc makes up approx 1.69% of Pembroke Management Ltd’s portfolio.
Acadia Healthcare Company Inc opened for trading at $57.83 and hit $58.28 on the upside on Wednesday, eventually ending the session at $57.83, with a gain of 0.64% or 0.37 points. The heightened volatility saw the trading volume jump to 4,00,936 shares. Company has a market cap of $5,056 M.
On the company’s financial health, Acadia Healthcare Company Inc reported $0.55 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.54. The company had revenue of $616.80 million for the quarter, compared to analysts expectations of $612.77 million. The company’s revenue was up 68.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS.
Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Company shares were Reiterated by Mizuho on Apr 29, 2016 to “Buy”, Firm has raised the Price Target to $ 71 from a previous price target of $66 .Shares were Reiterated by Jefferies on Feb 17, 2016 to “Buy” and Lowered the Price Target to $ 85 from a previous price target of $100 .
Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.